av/sun-pharmaceutical--big.svg

COM:SUNPHARMA

Sun Pharmaceutical Industries Ltd.

  • Stock

Last Close

1,780.00

22/11 10:00

Market Cap

3.80T

Beta: -

Volume Today

1.42M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
160.04B
-
272.87B
70.49%
277.33B
1.63%
299.94B
8.15%
260.65B
13.10%
286.86B
10.06%
286.86B
0%
331.39B
15.52%
384.26B
15.95%
384.26B
0%
484.97B
26.21%
cost of revenue
33.78B
-
77.76B
130.21%
74.91B
3.67%
94.25B
25.82%
88.26B
6.36%
92.39B
4.68%
92.39B
0%
98.85B
7.00%
117.08B
18.43%
117.08B
0%
226.48B
93.45%
gross profit
126.27B
-
195.11B
54.52%
202.42B
3.75%
205.69B
1.62%
172.39B
16.19%
194.48B
12.81%
194.48B
0%
232.54B
19.57%
267.19B
14.90%
267.19B
0%
258.49B
3.26%
selling and marketing expenses
16.07B
-
28.20B
75.49%
27.38B
2.90%
21.87B
20.14%
15.01B
31.35%
21.06B
40.27%
21.06B
0%
24.82B
17.85%
32.82B
32.24%
32.82B
0%
57.80B
76.13%
general and administrative expenses
5.71B
-
16.42B
187.64%
21.19B
29.02%
16.67B
21.32%
18.46B
10.76%
16.96B
8.12%
16.96B
0%
23.85B
40.61%
21.87B
8.32%
21.87B
0%
34.37B
57.17%
selling general and administrative expenses
21.78B
-
44.62B
104.89%
48.57B
8.85%
38.54B
20.66%
33.48B
13.13%
38.02B
13.58%
38.02B
0%
48.67B
28.00%
54.69B
12.36%
54.69B
0%
122.90B
124.75%
research and development expenses
19.13B
-
21.03B
-
21.33B
1.41%
31.28B
-
other expenses
915.60M
-
1.42B
55.59%
1.00B
29.66%
554M
44.71%
894.80M
61.52%
1.48B
64.99%
1.48B
0%
656.80M
55.51%
569.50M
13.29%
127.73B
22,328.55%
13.54B
89.40%
cost and expenses
92.57B
-
204.41B
120.81%
202.74B
0.82%
214.45B
5.77%
219.78B
2.49%
239.62B
9.03%
239.62B
0%
267.21B
11.52%
299.49B
12.08%
299.49B
0%
380.66B
27.10%
operating expenses
58.80B
-
126.65B
115.40%
127.84B
0.94%
120.20B
5.97%
131.52B
9.42%
147.23B
11.94%
147.23B
0%
168.36B
14.35%
182.42B
8.35%
182.42B
0%
154.18B
15.48%
interest expense
223.80M
-
1.81B
706.66%
2.41B
33.60%
3.30B
36.96%
4.52B
36.68%
5.25B
16.33%
5.25B
0%
1.41B
73.14%
1.27B
9.74%
1.27B
0%
2.38B
87.26%
ebitda
75.33B
-
80.52B
6.88%
86.33B
7.22%
106.06B
22.86%
61.59B
41.93%
71.94B
16.81%
71.94B
0%
90.54B
25.86%
116.00B
28.13%
116.00B
0%
129.87B
11.95%
operating income
67.47B
-
68.46B
1.46%
74.58B
8.95%
85.49B
14.62%
40.87B
52.19%
47.37B
15.91%
47.25B
0.27%
64.28B
36.04%
81.47B
26.75%
94.57B
16.07%
104.30B
10.30%
depreciation and amortization
4.09B
-
11.95B
191.94%
10.14B
15.17%
12.65B
24.79%
15.00B
18.59%
17.53B
16.90%
17.53B
0%
20.80B
18.63%
21.44B
3.07%
21.44B
0%
167.90K
100.00%
total other income expenses net
-21.64B
-
-4.43B
79.55%
-6.93B
56.61%
4.99B
171.94%
-6.08B
221.92%
-9.29B
52.72%
-9.14B
1.52%
-36.41B
298.11%
-36.82B
1.15%
-49.75B
35.11%
6.58B
113.21%
income before tax
45.83B
-
64.03B
39.71%
67.65B
5.66%
90.48B
33.74%
34.79B
61.55%
38.10B
9.52%
38.10B
0%
27.99B
26.53%
44.81B
60.08%
44.81B
0%
110.88B
147.42%
income tax expense
7.02B
-
9.15B
30.27%
9.35B
2.21%
12.12B
29.59%
8.45B
30.24%
6.01B
28.91%
6.01B
0%
5.15B
14.34%
10.76B
108.96%
10.76B
0%
14.39B
33.84%
net income
31.41B
-
45.39B
44.50%
47.16B
3.89%
69.64B
47.68%
21.62B
68.96%
26.65B
23.31%
26.65B
0%
29.04B
8.94%
32.73B
12.70%
32.73B
0%
95.76B
192.61%
weighted average shs out
2.07B
-
2.40B
16.12%
2.41B
0.06%
2.40B
0.13%
2.40B
0.17%
2.40B
0.00%
2.40B
0%
2.40B
0.00%
2.41B
0.30%
2.40B
0.29%
2.40B
0%
weighted average shs out dil
2.07B
-
2.41B
16.17%
2.41B
0.05%
2.40B
0.16%
2.40B
0.17%
2.40B
0.00%
2.40B
0%
2.40B
0.00%
2.41B
0.30%
2.40B
0.29%
2.40B
0%
eps
15.20
-
18.90
24.34%
18.90
0%
29
53.44%
9.01
68.93%
11.11
23.31%
11.11
0%
12.10
8.91%
13.60
12.40%
13.64
0.29%
39.90
192.52%
epsdiluted
15.20
-
18.90
24.34%
18.90
0%
29
53.44%
9.01
68.93%
11.11
23.31%
11.11
0%
12.10
8.91%
13.60
12.40%
13.64
0.29%
39.90
192.52%

All numbers in (except ratios and percentages)